摘要:
Provided is a process for continuously producing xylitol in high yield and productivity using a vacuum microfiltration bioreactor containing a fermentation medium for a strain of the genus Candida, which includes: 5 300 g/l of xylose, 1 10 g/l of urea, 1 10 g/l of potassium diphosphate, 0.01 1 g/l of magnesium sulfate, 0.1-10 mg/l of MnSO4.4H2O, 0.1 10 mg/l of CoCl2.6H2O, 0.1 10 mg/l of NaMoO4.2H2O, 0.1 10 mg/l of ZnSO4.7H2O, 0.1 10 mg/l of AlCl3.6H2O, 0.1 10 mg/l of CuCl2.2H2O, 0.01-5 mg/l of H3BO3, 1-100 mg/l of FeSO4 7H2O, 0.1-10 mg/l of ascorbic acid, 1-100 mg/l of biotin, 1-100 mg of choline, 1-200 mg/l of folic acid, 1-100 mg/l of inositol, 1-100 mg/l of nicotinic acid, 0.1-10 mg/l of p-aminobezoic acid, 1-100 mg/l of pantothenic acid, 0.1-10 mg/l of pyridoxine, 10-1,000 mg/l of riboflavin, and 1-100 mg/l of thiamine.
摘要:
Provided is a process for continuously producing xylitol in high yield and productivity using a vacuum microfiltration bioreactor containing a fermentation medium for a strain of the genus Candida, which includes: 5 300 g/l of xylose, 1 10 g/l of urea, 1 10 g/l of potassium diphosphate, 0.01 1 g/l of magnesium sulfate, 0.1-10 mg/l of MnSO4.4H2O, 0.1 10 mg/l of CoCl2.6H2O, 0.1 10 mg/l of NaMoO4.2H2O, 0.1 10 mg/l of ZnSO4.7H2O, 0.1 10 mg/l of AlCl3.6H2O, 0.1 10 mg/l of CuCl2.2H2O, 0.01-5 mg/l of H3BO3, 1-100 mg/l of FeSO4 7H2O, 0.1-10 mg/l of ascorbic acid, 1-100 mg/l of biotin, 1-100 mg of choline, 1-200 mg/l of folic acid, 1-100 mg/l of inositol, 1-100 mg/l of nicotinic acid, 0.1-10 mg/l of p-aminobezoic acid, 1-100 mg/l of pantothenic acid, 0.1-10 mg/l of pyridoxine, 10-1,000 mg/l of riboflavin, and 1-100 mg/l of thiamine.
摘要:
Provided is a process for continuously producing xylitol in high yield and productivity using a vacuum microfiltration bioreactor containing a fermentation medium for a strain of the genus Candida, which includes: 5 300 g/l of xylose, 1 10 g/l of urea, 1 10 g/l of potassium diphosphate, 0.01 1 g/l of magnesium sulfate, 0.1-10 mg/l of MnSO404H2O, 0.1 10 mg/l of CoCl2-6H2O, 0.1 10 mg/l of NaMoO4-2H2O, 0.1 10 mg/l of ZnSO4-7H2O, 0.1 10 mg/l of AlCl3-6H2O, 0.1 10 mg/l of CuCl2-2H2O, 0.01-5 mg/l of H3BO3, 1-100 mg/l of FeSO4 7H2O, 0.1-10 mg/l of ascorbic acid, 1-100 mg/l of biotin, 1-100 mg of choline, 1-200 mg/l of folic acid, 1-100 mg/l of inositol, 1-100 mg/l of nicotinic acid, 0.1-10 mg/l of p-aminobezoic acid, 1-100 mg/l of pantothernic acid, 0.1-10 mg/l of pyridoxine, 10-1,000 mg/l of riboflavin, and 1-100 mg/l of thiamine.
摘要:
Provided is a process for continuously producing xylitol in high yield and productivity using a vacuum microfiltration bioreactor containing a fermentation medium for a strain of the genus Candida, which includes: 5 300 g/l of xylose, 1 10 g/l of urea, 1 10 g/l of potassium diphosphate, 0.01 1 g/l of magnesium sulfate, 0.1-10 mg/1 of MnSO404H2O, 0.1 10 mg/1 of CoCl2-6H2O, 0.1 10 mg/1 of NaMoO4-2H2O, 0.1 10 mg/1 of ZnSO4-7H2O, 0.1 10 mg/1 of AlCl3-6H2O, 0.1 10 mg/1 of CuCl2-2H2O, 0.01-5 mg/1 of H3BO3, 1-100 mg/1 of FeSO4 7H2O, 0.1-10 mg/1 of ascorbic acid, 1-100 mg/1 of biotin, 1-100 mg of choline, 1-200 mg/1 of folic acid, 1-100 mg/1 of inositol, 1-100 mg/1 of nicotinic acid, 0.1-10 mg/1 of p-aminobezoic acid, 1-100 mg/1 of pantothernic acid, 0.1-10 mg/1 of pyridoxine, 10-1,000 mg/1 of riboflavin, and 1-100 mg/1 of thiamine.
摘要:
The present invention relates to a manufacturing method of tagatose using galactose isomerization of high yield, more particularly a method to enhance conversion rate of isomerization by adding borate which binds specifically to tagatose and a manufacturing method of tagatose using the same.
摘要:
The present invention relates to a manufacturing method of tagatose using galactose isomerization of high yield, more particularly a method to enhance conversion rate of isomerization by adding borate which binds specifically to tagatose and a manufacturing method of tagatose using the same.
摘要:
The present invention relates to novel retinol derivatives, the methods of preparation and the uses thereof. According to the present invention, retinol derivatives comprise carboester linkage between di-, tri-, polypeptide having functional group of COOH and retinol. Retinol derivatives in the present invention comprise carboester linkage between amino acid having functional group of di-COOH and retinol. Retinol derivatives comprise carboester linkage between retinol and the compounds having the function group of COOH and multiple double bonds on carbon chain. Retinol derivatives in the present invention comprise carboester linkage between retinol and the compounds having the functional group of di-COOH and one double bond. Retinol derivatives in the present invention comprise ether linkage between the compounds with OH functional group and retinol.